drugset / Trial / NCT00002749

Carboplatin in Patients With Progressive Gliomas

NCT00002749 ↗

Phase 2 Completed 25 enrolled Duke University
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carboplatin in patients with progressive glioma.

Timeline

Start
1993-02
Primary completion
—
Completion
2000-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —